| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
23,157 |
20,887 |
$3.63M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
8,689 |
7,799 |
$1.96M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
19,152 |
17,158 |
$1.92M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
55,857 |
49,317 |
$1.52M |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
25,092 |
22,230 |
$582K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
8,094 |
6,808 |
$460K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,355 |
1,201 |
$388K |
| 80053 |
Comprehensive metabolic panel |
38,345 |
33,750 |
$305K |
| 80061 |
Lipid panel |
19,201 |
17,627 |
$200K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
27,541 |
23,867 |
$155K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
1,418 |
1,217 |
$153K |
| 87536 |
|
2,071 |
1,875 |
$132K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
813 |
751 |
$128K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,816 |
1,399 |
$128K |
| 36415 |
Collection of venous blood by venipuncture |
56,831 |
49,437 |
$122K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
1,569 |
1,417 |
$117K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
2,989 |
2,353 |
$115K |
| 80050 |
General health panel |
3,186 |
2,953 |
$111K |
| 71046 |
Radiologic examination, chest; 2 views |
2,773 |
2,484 |
$107K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
12,885 |
11,764 |
$96K |
| 87428 |
|
3,528 |
3,032 |
$92K |
| 76830 |
Ultrasound, transvaginal |
771 |
710 |
$85K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
2,048 |
1,435 |
$72K |
| 86360 |
|
1,960 |
1,789 |
$70K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
3,405 |
2,974 |
$69K |
| 84443 |
Thyroid stimulating hormone (TSH) |
4,389 |
3,994 |
$57K |
| 86359 |
|
1,967 |
1,788 |
$56K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
73 |
65 |
$54K |
| 71045 |
Radiologic examination, chest; single view |
1,366 |
1,192 |
$50K |
| 81025 |
|
7,791 |
6,879 |
$50K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
857 |
724 |
$50K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,827 |
1,552 |
$49K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,365 |
1,266 |
$43K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
5,988 |
5,512 |
$42K |
| 83880 |
|
1,861 |
1,651 |
$40K |
| 81001 |
|
16,918 |
14,816 |
$39K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
254 |
150 |
$37K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,164 |
1,071 |
$29K |
| Q3014 |
Telehealth originating site facility fee |
1,560 |
1,523 |
$27K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
996 |
846 |
$27K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
992 |
846 |
$27K |
| 84484 |
|
3,571 |
2,990 |
$26K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
528 |
439 |
$24K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
1,062 |
993 |
$24K |
| 85027 |
|
4,236 |
3,728 |
$21K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
432 |
369 |
$20K |
| 90686 |
|
1,654 |
1,600 |
$20K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
28 |
28 |
$20K |
| 80074 |
|
444 |
417 |
$19K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
747 |
705 |
$16K |
| 86357 |
|
587 |
527 |
$16K |
| 86355 |
|
587 |
528 |
$16K |
| 84153 |
|
1,133 |
1,054 |
$16K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
692 |
634 |
$16K |
| 70450 |
Computed tomography, head or brain; without contrast material |
47 |
38 |
$14K |
| 82043 |
|
3,078 |
2,820 |
$14K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
981 |
957 |
$14K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
289 |
216 |
$14K |
| 82570 |
|
3,217 |
2,941 |
$13K |
| 90674 |
|
865 |
784 |
$12K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
263 |
222 |
$12K |
| 84466 |
|
1,196 |
1,073 |
$11K |
| 90715 |
|
232 |
226 |
$11K |
| 90732 |
|
90 |
86 |
$10K |
| 82150 |
|
1,956 |
1,711 |
$9K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
472 |
397 |
$8K |
| 84403 |
|
463 |
426 |
$8K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,424 |
1,268 |
$8K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
140 |
112 |
$8K |
| 0002A |
|
237 |
211 |
$8K |
| 0001A |
|
245 |
197 |
$7K |
| 80069 |
|
1,253 |
1,093 |
$7K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
424 |
362 |
$7K |
| 87522 |
Neg quan hep c or qual rna |
167 |
164 |
$6K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
165 |
155 |
$6K |
| 86803 |
|
547 |
482 |
$6K |
| 83540 |
|
1,286 |
1,154 |
$6K |
| 87210 |
|
1,317 |
1,148 |
$5K |
| G0433 |
Infectious agent antibody detection by enzyme-linked immunosorbent assay (elisa) technique, hiv-1 and/or hiv-2, screening |
346 |
312 |
$5K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
15 |
13 |
$5K |
| 83605 |
|
581 |
489 |
$4K |
| 87081 |
|
602 |
582 |
$4K |
| 83970 |
|
174 |
151 |
$4K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
204 |
102 |
$4K |
| 86480 |
|
56 |
55 |
$3K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
12 |
12 |
$3K |
| 84100 |
|
1,324 |
1,123 |
$3K |
| 82728 |
|
348 |
280 |
$3K |
| 86592 |
|
814 |
722 |
$3K |
| 82947 |
|
1,040 |
776 |
$2K |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
87 |
79 |
$2K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
46 |
26 |
$2K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
74 |
69 |
$2K |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
343 |
215 |
$2K |
| 90656 |
|
158 |
119 |
$2K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
431 |
335 |
$2K |
| 90670 |
|
13 |
13 |
$2K |
| 85610 |
|
647 |
555 |
$1K |
| 82962 |
|
693 |
544 |
$1K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
302 |
207 |
$1K |
| 82607 |
|
76 |
64 |
$873.99 |
| 92228 |
|
36 |
27 |
$801.36 |
| J1380 |
Injection, estradiol valerate, up to 10 mg |
95 |
64 |
$773.06 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
31 |
28 |
$538.63 |
| 82550 |
|
117 |
99 |
$500.90 |
| 83001 |
|
27 |
24 |
$427.34 |
| 86705 |
|
40 |
38 |
$424.72 |
| 87340 |
|
41 |
38 |
$372.76 |
| 83735 |
|
89 |
71 |
$355.10 |
| 85730 |
|
95 |
80 |
$286.79 |
| 85379 |
|
37 |
35 |
$285.04 |
| 86756 |
|
14 |
14 |
$222.46 |
| 84439 |
|
39 |
32 |
$219.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
12 |
12 |
$212.47 |
| 81003 |
|
156 |
126 |
$197.48 |
| 91300 |
|
733 |
549 |
$185.40 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
143 |
136 |
$170.89 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
26 |
25 |
$146.05 |
| 86706 |
|
15 |
14 |
$128.88 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
18 |
14 |
$119.84 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
37 |
24 |
$114.74 |
| 87040 |
|
12 |
12 |
$113.52 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
239 |
183 |
$89.03 |
| J2704 |
Injection, propofol, 10 mg |
604 |
516 |
$88.59 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
251 |
194 |
$87.93 |
| A4216 |
Sterile water, saline and/or dextrose, diluent/flush, 10 ml |
21 |
17 |
$76.23 |
| 84156 |
|
40 |
25 |
$62.39 |
| 90662 |
|
131 |
124 |
$0.00 |
| 84681 |
|
14 |
13 |
$0.00 |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
35 |
25 |
$0.00 |
| 00000 |
|
653 |
516 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
38 |
28 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
276 |
269 |
$0.00 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
83 |
77 |
$0.00 |
| 90480 |
|
15 |
14 |
$0.00 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
34 |
26 |
$0.00 |
| 90694 |
|
16 |
16 |
$0.00 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
21 |
13 |
$0.00 |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
37 |
37 |
$0.00 |